Unyango lweNtsholongwane yeNtsholongwane yeNtshona luxhomekeke kubunzima bokugula okubangela. Ingabangela uluhlu lweempawu zesifo sekliniki, ukusuka kwisifo esifana nesifo sofuba (okanye akukho zibonakaliso nakwezinye) kwisifo esisongela ubomi be-neurological disease nge- meningitis okanye nge- encephalitis .
Hlola oko kuvame ukucetyiswa kuzo zombini iziganeko, kunye neengcebiso zokukhusela kunye nokunye.
Izifo eziseMild West Nile
Abantu abahlakulela ibhokisi elincinci le-West Nile fever bafumana udibaniso lwe-fever, aches muscle, intloko, ubuthathaka kunye nokukhathala, umqala, kunye neengxaki zentlungu.
Aba bantu bavame ukuxilonga "ngehlobo elibi lokubanda," baze baziphathe ngendlela efanelekileyo kunye nokuphumla, ukusetyenziswa kwamanzi kunye nezilwanyana. Oogqirha abaqhelekanga ukubandakanyeka, kwaye abantu abane-TB eNew West bayagula ngokugcwele ngokupheleleyo kwiintsuku ezimbalwa.
Usulelo lweNayile eNtshona
Ngelishwa, intsholongwane yaseNtshona yeNtshonalanga nayo ingabangela ukugula okungakumbi, ngakumbi ukuba ingena kwinkqubo ye-nervous central kwaye ibangela i-meningitis okanye i-encephalitis. Abantu abanolu hlobo lwesifo banokufumana umkhuhlane ophezulu, ukukhubazeka, ukudideka, ukuxhatshazwa, i-coma, nokufa. Unyango olunyamekayo kumntu onentsholongwane ephezulu yeNtsholongwane yeNayile.
Unyango lwabantu abaneentsholongwane ezinzulu zentsholongwane yeNtshona Nile luxhasa kakhulu.
Oko kukuthi, amanyathelo amanyathelo athatyathwayo ukuze ahlawule umkhuhlane, agcine amazinga okumisa amanzi, kwaye agcine ukuzinza kwe-metabolic and cardiovascular-ngelixa elinde iimpendulo zomzimba zomzimba ekugqibeleni ukususa intsholongwane. Amanyathelo anjalo angadinga unyango kwiyunithi yokunyamekela, mhlawumbi iiveki okanye ngaphezulu.
Imithi yokulwa neyeza
Ulwaphulo lwe-antitiviral alubonakalwanga kwizilingo zeklinikhi ukuba luncedo olunokulinganisela kubantu abaneentsholongwane ezinzulu zentsholongwane yaseWest Nile. Nangona kunjalo, uninzi lwezo zonyango luye lwazama, kwaye kukho iingxelo ze-anecdotal zentlawulo.
Ama-anti-antial agqityiweyo adibeneyo afaka:
- I-Ribavarin : Iingeniso zalo mhlaza weNtsholongwane yaseNtshonalanga yeNtsholongwane ngokubanzi ziyi-theory-ayizange iboniswe ukuba isebenze kwimifanekiso yezilwanyana. Kwilinye ilingo lonyango elingalawulekiyo ngexesha leNtshonalanga yeNayile kuYisraeli, le nkunkuma yayifumaneka ingasebenzi.
- I-immunoglobulin engabonakaliyo: Kwakhona kwakhona, inzuzo enokubakho nge- immunoglobulin (IVIG) ene- intravenous isoretical . Ukwenza i- antibodies (immunoglobulin) kwiNtsholongwane yaseNtshonalanga kucatshangelwa ukuba yindlela ephakamileyo abantu abayichitha ngayo intsholongwane, ngoko kunika i-IVIG enamazinga aphezulu ase-West Nile antibodies "okufanele" ukusebenza. Ngelishwa, ilingo lonyango lonyango olwenziwe ngolu hlobo olwenziweyo ukuvavanya umphumo we-IVIG kwiNtsholongwane yaseNtshonalanga ayizange ibonise inzuzo.
- Interferon. I-Interferon ibonakala iyasebenza kwiNtsholongwane yaseNtshonalanga xa ivavanywa kwizilwanyana ezithile. Kodwa zimbalwa iingxelo ezazisasazekayo ezixhamlayo kwizigulane eziphathwe nge-interferon ziye zabikwa; Ezinye iingxelo ziphakamise ukuba i-interferon ingabangela ingozi.
Ukubonelelwa ngeli lizwi ngemithi yokulwa neyeza, sinokuthi kuphela le ndlela ayizange iqiniseke ngokuthe ngqo. Ukunyamekela ngokunyamekela kuyisona sigqirha sonyango losulelo lweNtshonalanga yeNayile.
Thintelo
I-"yonyango" engcono yegciwane leNtshonalanga yeNayile likhusela. Amanyathelo okukhusela iintsholongwane zentsholongwane yeNtshona yeNayile zibandakanya:
- Iiprogram zokulawula ummi. Iiprogram zokulawula ummi zingasetyenziselwa ukuqeda iindawo zokuzalisa ummi, kwaye ama-agent angama-larvicidal anokufuthwa ukuze abulale izibungu zamanthambo ngaphambi kokuba zibe ngabantu abadala. Amanyathelo enkqubo yoluntu, xa sele esetyenziswe ngokucwangcisekileyo, aye waboniswa ekunciphiseni iziganeko zentsholongwane yaseNtshonalanga kwezinye iindawo.
- Amanyathelo okukhusela. Kufuneka ugcine ipropati yakho icacile ngamachibi aphantsi okanye ama-puddles angaba yindawo yokuzalisa ummiyane. Ngaphandle kwexesha, ngokukhawuleza ngexesha lokuhlwa okanye ukusa, xa i-mosquito ihlala iyasebenza kakhulu, kufuneka usebenzise izilwanyana ezinqabileyo, kwaye ugcine uninzi lwesikhumba sakho.
- Iiprogram zokucoca ngegazi. Kwamazwe amaninzi athuthukileyo, ukunikezela ngemveliso yegazi kuhlolwe ukuvela kwintsholongwane yeNtsholongwane yeNtshonalanga ngaphambi kokuba igxilwe. Oku kuqaphelwa ukuba kuthintele umngcipheko wokufumana intsholongwane yeNtshonalanga yeNayile kwigazi (kwaye loo mngcipheko wawuphantsi kakhulu kwindawo yokuqala).
Ukugonywa
Imizamo enzima kakhulu isebenzayo ukuphucula iigcino kwiNtsholongwane yeNayile eNtshona. Enyanisweni, izitofu ezininzi sele sele zivunyelwe ihashe (ezinokuthi zigule kakhulu ngegciwane leNtshonalanga yeNayile). Nangona kunjalo, ukufumana imvume yokusetyenziswa kwabantu, nale nto okanye nayiphi na unyango unyango, luyinkqubo enamandla kakhulu kwaye idla ixesha elide kunezilwanyana.
Sekunjalo, iintsholongwane zabantu ezinxamnye nentsholongwane yaseNtshonalanga yeNayile zivavanywa ngoku, kwaye iingxelo zangaphambili zibonisa ukuba ubuncinci babo babethembisa. Kodwa akukho nanjalo kwezi zitofu ezinokuthi ziqalise izilingo zesigaba se-3 (ukugqibela, inyathelo elide ngaphambi kokuvunyelwa kwe-FDA), kwaye kulindeleke ukuba akukho gonyo lwe-West Nile luya kuvunywa ukusetyenziswa kwabantu ngaphambi ko-2020, ekuqaleni.
> Imithombo:
> Dayan GH, Bevilacqua J, Coleman D, et al. Isigaba Ii-Ii-Ii-Ranging Ranging Isifundo soKhuseleko kunye no-Immunogenicity of Dose Single I-Vaccine yeNayile yase-West KwiiNtsholongwane eziMpilo ≥ 50 iminyaka yobudala. Iigciwane 2012; 30: 6656.
> Lothrop HD, i-Lothrop BB, i-Gomsi DE, et al. Izicelo ze-Adulticide zeNkcazo zeNkcazo zokuNciphisa i-Arbovirus Transmission Kuphela kwi-Coachella Valley, Riverside County, California. Umtsalane Borne Zoonotic Dis 2008; 8: 475.
> Morrey JD, Day CW, Julander JG, et al. Impembelelo ye-Interferon-Alpha kunye ne-Interferon-Inducers Kwi-Virtual Nile Virus Kwiimouse kunye ne-Hamster zeZilwanyana zeMfuyo. Antivir Chem Chemother 2004; 15: 101.